Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Charts for Quick CASH $$$ -- Ignore unavailable to you. Want to Upgrade?

To: Galirayo who wrote (4602)	10/26/1997 8:16:00 PM
From: rebecca	Read Replies (1) \| Respond to of 9262

Your charts noted Dusa back in August. Accumulation probably started at that point since clinical data was expected to be released sometime in October. This biotech company and the group in general often follow a progressive momentum play on pending release of data. Richard, has brought some of these other biotech plays to the boards attention over the past few weeks. Genelab, which did very well several weeks ago and retraced is anticpating release of key data on November 12th. Any thoughts?? rebecca